The necrosis sign in magnetic resonance-mammography: Diagnostic accuracy in 1,084 histologically verified breast lesions

Breast Journal

Volumn 16, Issue 6, 2010, Pages 603-608

  Dietzel, Matthias ^a   Baltzer, Pascal A T ^a   Vag, Tibor ^b   Herzog, Aimee ^a   Gajda, Mieczyslaw ^c   Camara, Oumar ^a   Kaiser, Werner A ^a,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Institute of Pathology   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

breast; central necrosis; MR mammography; MRI; sensitivity; specificity; T2

Indexed keywords

GADOLINIUM PENTETATE;

ARTICLE; BREAST BIOPSY; BREAST LESION; CANCER GRADING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NECROSIS;

EID: 78449312894     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00982.x     Document Type: Article

References (32)

1. Mameri CS, Kemp C, Goldman SM, Sobral LA, Ajzen S,. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J 2008; 14: 236-44.
2. Malich A, Fischer DR, Wurdinger S, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol 2005; 185: 964-70.
3. Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH,. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008; 246: 116-24.
4. Geraghty PR, Van Den Bosch MA, Spielman DM, et al. MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma. Breast J 2008; 14: 574-80.
5. Tardivon AA, Athanasiou A, Thibault F, El Khoury C,. Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol 2007; 61: 212-5. (Pubitemid 46096699)
6. Baltzer PA, Dietzel M, Vag T, et al., Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography? Rofo 2009; 182: 254-60.
7. Williams TC, DeMartini WB, Partridge SC, Peacock S, Lehman CD,. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Radiology 2007; 244: 94-103.
8. Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA,. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol 2008; 43: 236-42.
9. Thomas MA, Lipnick S, Velan SS, et al. Investigation of breast cancer using two-dimensional MRS. NMR Biomed 2009; 22: 77-91.
10. Mountford C, Ramadan S, Stanwell P, Malycha P,. Proton MRS of the breast in the clinical setting. NMR Biomed 2009; 22: 54-64.
11. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008; 28: 1157-65.
12. Baltzer PA, Renz DM, Herrmann KH, et al., Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009; 19: 1612-20.
13. Ikeda MD,. MRI Lexicon: what should be improved? Eur Radiol 2006; 16 (Suppl. 5): E49-50.
14. Fischer DR, Baltzer P, Malich A, et al. Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography? Eur Radiol 2004; 14: 394-401.
15. Bell HS, Whittle IR, Walker M, Leaver HA, Wharton SB,. The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems. Neuropathol Appl Neurobiol 2001; 27: 291-304.
16. Dietzel M, Baltzer PAT, Vag T, et al. The adjacent vessel sign in MR-Mammography - new data and subgroup analysis in 1084 histologically verified cases. Korean J Radiol 2010; 11: 178-86.
17. Armitage P, Berry G,. Statistical Methods in Medical Research, 3rd edn. London: Blackwell, 1994.
18. Newcombe RG,. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857-72.
19. Folkman J, Shing Y,. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
20. Bässsler R,. Mamma. In:, Remmele W, ed. Pathologie. Berlin, Heidelberg, New York: Springer, 1997: 135-368.
21. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639-49.
22. Carlomagno C, Perrone F, Lauria R, et al. Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 1995; 52: 272-7.
23. Mann RM, Hoogeveen YL, Blickman JG, Boetes C,. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008; 107: 1-14.
24. Yeh ED, Slanetz PJ, Edmister WB, Talele A, Monticciolo D, Kopans DB,. Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J 2003; 9: 13-8.
25. Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 1994; 162: 1307-11. (Pubitemid 24187477)
26. Jimenez RE, Wallis T, Visscher DW,. Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol 2001; 25: 331-7.
27. Kawashima M, Tamaki Y, Nonaka T, et al. MR imaging of mucinous carcinoma of the breast. AJR Am J Roentgenol 2002; 179: 179-83.
28. Tominaga J, Hama H, Kimura N, Takahashi S,. MR imaging of medullary carcinoma of the breast. Eur J Radiol 2009; 70: 525-9.
29. Okafuji T, Yabuuchi H, Sakai S, et al. MR imaging features of pure mucinous carcinoma of the breast. Eur J Radiol 2006; 60: 405-13.
30. Wurdinger S, Herzog AB, Fischer DR, et al. Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol 2005; 185: 1317-21.
31. Franceschini G, Masetti R, Brescia A, et al. Phyllodes tumor of the breast: magnetic resonance imaging findings and surgical treatment. Breast J 2005; 11: 144-5.
32. Soerjomataram I, Louwman MW, Ribot JG, et al., An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008; 107: 309-30.